Clinical Trial Update: Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis [Phase 3]

View source ↗

Summary

Phase 3 trial results show the efficacy and safety of Adalimumab in subjects with moderately to severely active ulcerative colitis. The study is completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Abbott | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2010-05-27